Allarity Therapeutics Inc (NASDAQ:ALLR) currently has a daily average trading volume of 2.39M but it saw 1559874 shares traded in last market. With a market cap of 16.86M USD, the company’s current market price of $1.01 came rising about 1.93 while comparing to the previous closing price of $0.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $103.80 and as low as $0.61. In the recent trading on the day, stock has struck highest price mark of $0.953 while lowest mark touched by it was $1.1.
Taking a look at 20-day trading activity of Allarity Therapeutics Inc (ALLR) gives us an average price of $0.8804, while its current price level is -99.03% below from 52-week high level whereas it is 64.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9241 while that of 200 days or SMA-200 reads an average of $2.1764. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.31% during that period while stretching the period over a month that increases to 14.85%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 57.61 which implies that the stock is in neutral territory.
Over the week, ALLR’s stock price is moving 20.02% up while it is 1.00% when we observe its performance for the past one month. Year-to-date it is -13.68% down and over the past year, the stock is showing a downside performance of -97.58%.
The company is expected to be releasing its next quarterly report on 2024-Nov-13, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Allarity Therapeutics Inc’s total number of outstanding shares is 17.01M with 4.38% of that held by the insiders while 0.61% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -214.85% and return on equity (ROE) at -541.17%. Stock’s beta reads -0.28. Stock has a price to book (P/B) ratio of 0.62. Its return on asset (ROA) is -142.07% on average.
